Masimo-PE Week Wire

July 20, 2007

Masimo Corp., an Irvine, Calif.-based provider of non-invasive patient monitoring products, has set its IPO terms to around 11.92 million common shares being offered at between $16 and $18 per share. It would have an initial market cap of around $950 million, if it were to price at the high end of its range. The company plans to trade on the NASDAQ under ticker symbol MASI, with Piper Jaffray and Deutsche Bank Securities serving as co-lead underwriters. Masimo has raised around $88 million in total VC funding since 1992, including a 2005 infusion at a $190 million post-money valuation. Backers include Invesco Private Capital (8.6% pre-IPO stake), Steelpoint Capital Partners (5.6%), DSV Partners (5.4%) and Franklin Templeton Group (5.3%). www.masimo.com

About Camden Partners

Camden Partners Holdings, LLC, founded in 1995, is a diversified investment management firm based in Baltimore, Maryland. The company operates private equity funds that focus on providing growth capital to emerging companies within the Business and Financial Services, Healthcare and Education sectors; Camden Partners Limited Partnership, a hedge fund featuring a balanced long-short strategy focusing on small cap public companies; and Camden Private Capital, a fund-of-funds, including Corporate Finance and Venture offerings. For more information visit http://www.camdenpartners.com.

<< Back